U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07726888) titled 'Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis:A Real-World Prospective Cohort Study.' on July 21.
Brief Summary: In a real-world setting, this study systematically evaluates the clinical efficacy and safety of guselkumab (GUS) in the treatment of ulcerative colitis (UC), encompassing multi-dimensional outcomes including clinical remission, biochemical remission, endoscopic remission, histologic healing, and intestinal ultrasound changes.
Study Start Date: Aug. 01
Study Type: OBSERVATIONAL
Condition:
Ulcerative Colitis (Disorder)
Guselkumab
Intervention:
DRUG: Guselkumab
All the patie...